• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过检测胰液中端粒酶活性诊断胰腺癌:与K-ras突变的比较

Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.

作者信息

Uehara H, Nakaizumi A, Tatsuta M, Baba M, Takenaka A, Uedo N, Sakai N, Yano H, Iishi H, Ohigashi H, Ishikawa O, Okada S, Kakizoe T

机构信息

Department of Gastroenterology, Osaka Medical Center for Cancer and Cardiovascular Disease, Higashinari, Japan.

出版信息

Am J Gastroenterol. 1999 Sep;94(9):2513-8. doi: 10.1111/j.1572-0241.1999.01386.x.

DOI:10.1111/j.1572-0241.1999.01386.x
PMID:10484017
Abstract

OBJECTIVE

Telomerase activity is reported to be specific and very frequent in human malignancy. K-ras mutations are also very frequently detected in pancreatic cancer, but their specificity for pancreatic cancer is controversial. We examined the telomerase activity and K-ras mutations in pancreatic juice from patients with pancreatic disease.

METHODS

Pancreatic juice was obtained endoscopically at endoscopic retrograde pancreatography from 10 patients with pancreatic cancer, three with chronic pancreatitis, and three with a normal pancreas. The telomerase activity in pancreatic juice was assayed by telomeric repeat amplification protocol. K-ras mutations in exon 1 codon 12 were examined by the two-step polymerase chain reaction combined with restriction enzyme digestion, followed by single-strand conformation polymorphism analysis and direct sequencing.

RESULTS

Telomerase activity of >5.0 was detected in eight of 10 (80%) subjects with pancreatic cancer, but in none with chronic pancreatitis or normal pancreas. K-ras mutations were detected not only in eight of 10 (80%) subjects with pancreatic cancer but also in two of three with chronic pancreatitis and in one of three with a normal pancreas.

CONCLUSIONS

It was shown that the detection of telomerase activity in pancreatic juice is a more useful diagnostic tool for pancreatic cancer than that of K-ras mutations.

摘要

目的

据报道,端粒酶活性在人类恶性肿瘤中具有特异性且非常常见。K-ras突变在胰腺癌中也经常被检测到,但其对胰腺癌的特异性存在争议。我们检测了胰腺疾病患者胰液中的端粒酶活性和K-ras突变。

方法

通过内镜逆行胰胆管造影术从10例胰腺癌患者、3例慢性胰腺炎患者和3例胰腺正常的患者中获取胰液。采用端粒重复序列扩增法检测胰液中的端粒酶活性。通过两步聚合酶链反应结合限制性内切酶消化,随后进行单链构象多态性分析和直接测序,检测第1外显子第12密码子的K-ras突变。

结果

10例胰腺癌患者中有8例(80%)检测到端粒酶活性>5.0,但慢性胰腺炎患者和胰腺正常者均未检测到。K-ras突变不仅在10例胰腺癌患者中的8例(80%)中被检测到,而且在3例慢性胰腺炎患者中的2例以及3例胰腺正常者中的1例中也被检测到。

结论

结果表明,检测胰液中的端粒酶活性对胰腺癌的诊断比检测K-ras突变更有用。

相似文献

1
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.通过检测胰液中端粒酶活性诊断胰腺癌:与K-ras突变的比较
Am J Gastroenterol. 1999 Sep;94(9):2513-8. doi: 10.1111/j.1572-0241.1999.01386.x.
2
Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.通过K-ras点突变和胰液细胞学检查诊断胰腺癌
Am J Gastroenterol. 1996 Aug;91(8):1616-21.
3
Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.通过对合格胰液样本中人端粒酶逆转录酶信使核糖核酸的检测诊断胰腺腺癌
Clin Cancer Res. 2001 Jul;7(7):1976-81.
4
Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.胰液中p53肿瘤抑制基因的突变检测及其在胰腺癌患者诊断中的应用:与K-ras突变的比较
Clin Cancer Res. 1999 May;5(5):1147-53.
5
Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.通过检测粪便和胰液中的K-ras和p53基因突变来诊断早期胰腺癌。
Chin Med J (Engl). 2002 Nov;115(11):1632-6.
6
p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.慢性胰腺炎患者胰液样本中的p53和K-ras突变
Gastrointest Endosc. 2001 Jun;53(7):734-43. doi: 10.1067/mge.2001.112711.
7
In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.胰液中的原位端粒酶活性可用于鉴别胰腺癌与其他胰腺疾病。
Pancreas. 2008 Apr;36(3):236-40. doi: 10.1097/MPA.0b013e31815bc1d6.
8
[An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].粪便及纯胰液中K-ras和p53基因突变检测在早期胰腺癌诊断中的应用价值
Zhonghua Yi Xue Za Zhi. 2001 Sep 10;81(17):1050-3.
9
Genetic diagnosis of pancreatic cancer.胰腺癌的基因诊断
J Hepatobiliary Pancreat Surg. 2002;9(1):39-44. doi: 10.1007/s005340200003.
10
A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.一种用于检测胰液端粒酶活性的高灵敏度定量检测方法,在诊断胰腺癌时不受聚合酶链反应抑制剂的影响:对连续100例患者的胰液样本进行分析。
Cancer. 2004 Nov 15;101(10):2309-17. doi: 10.1002/cncr.20649.

引用本文的文献

1
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.从端粒和端粒酶的角度理解、诊断和治疗胰腺癌。
Cancer Gene Ther. 2024 Sep;31(9):1292-1305. doi: 10.1038/s41417-024-00768-6. Epub 2024 Apr 9.
2
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.细胞衰老和衰老相关分泌表型在胰腺癌相关成纤维细胞中对胰腺癌恶性程度的影响。
Oncol Rep. 2023 May;49(5). doi: 10.3892/or.2023.8535. Epub 2023 Mar 31.
3
An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
胰腺癌中 mRNA、miRNA 和信号通路的综合数据分析。
Biochem Genet. 2021 Oct;59(5):1326-1358. doi: 10.1007/s10528-021-10062-x. Epub 2021 Apr 3.
4
Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer.利用体液进行胰腺癌早期检测的分子方法
Diagnostics (Basel). 2021 Feb 22;11(2):375. doi: 10.3390/diagnostics11020375.
5
Telomerase activity in the differential diagnosis of pancreatic mass.端粒酶活性在胰腺肿块鉴别诊断中的应用
J Gastrointest Oncol. 2019 Dec;10(6):1094-1098. doi: 10.21037/jgo.2019.08.07.
6
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.肿瘤周围SPARC表达与可切除性肝内胆管癌患者的预后
Onco Targets Ther. 2015 Jul 28;8:1899-907. doi: 10.2147/OTT.S78728. eCollection 2015.
7
Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.胰腺癌细胞株中人类端粒酶活性诊断作用的定量评估。 (注:原文中“from pancreatic juice”表述有误,根据语境推测应该是“from pancreatic cancer cell lines”,按照正确内容翻译如上。若按照给定原文准确翻译为:来自胰液的人类端粒酶活性在胰腺癌诊断作用中的定量评估 )
Tumour Biol. 2014 Aug;35(8):7897-904. doi: 10.1007/s13277-014-2053-3. Epub 2014 May 15.
8
Screening for pancreatic cancer: why, how, and who?胰腺癌筛查:为何、如何以及针对谁?
Ann Surg. 2013 Jan;257(1):17-26. doi: 10.1097/SLA.0b013e31825ffbfb.
9
Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2.采用 DIGE 技术对胰腺癌患者血清蛋白质谱进行蛋白质组学分析:甘露糖结合凝集素 2 和肌球蛋白轻链激酶 2 的上调。
BMC Gastroenterol. 2010 Jun 29;10:68. doi: 10.1186/1471-230X-10-68.
10
Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.用于胰腺癌血清生物标志物发现的稳定同位素稀释多维液相色谱-串联质谱法
J Proteome Res. 2009 Mar;8(3):1565-76. doi: 10.1021/pr800904z.